146 related articles for article (PubMed ID: 14609454)
1. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
2. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.
Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM
Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.
Smoot LM; McCormick JK; Smoot JC; Hoe NP; Strickland I; Cole RL; Barbian KD; Earhart CA; Ohlendorf DH; Veasy LG; Hill HR; Leung DY; Schlievert PM; Musser JM
Infect Immun; 2002 Dec; 70(12):7095-104. PubMed ID: 12438391
[TBL] [Abstract][Full Text] [Related]
4. Streptococcal toxic shock syndrome following total thyroidectomy.
Hung JA; Rajeev P
Ann R Coll Surg Engl; 2013 Oct; 95(7):457-60. PubMed ID: 24112488
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of Antigen-Specific Class-Switched B Cells from Individuals Naturally Immunized by Infection with Group A Streptococcus.
Lamb CL; Price E; Field KP; Dayton C; McIndoo ER; Katahira EJ; Stevens DL; Hobdey SE
mSphere; 2019 Nov; 4(6):. PubMed ID: 31694896
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.
Kulhankova K; King J; Salgado-Pabón W
Immunol Res; 2014 Aug; 59(1-3):182-7. PubMed ID: 24816557
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
[TBL] [Abstract][Full Text] [Related]
8. Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.
Wang P; Fredj Z; Zhang H; Rong G; Bian S; Sawan M
J Immunol Res; 2024; 2024():2313062. PubMed ID: 38268531
[TBL] [Abstract][Full Text] [Related]
9. Correlates of immunity to Group A Streptococcus: a pathway to vaccine development.
Frost H; Excler JL; Sriskandan S; Fulurija A
NPJ Vaccines; 2023 Jan; 8(1):1. PubMed ID: 36650164
[TBL] [Abstract][Full Text] [Related]
10. A brief review on Group A Streptococcus pathogenesis and vaccine development.
Castro SA; Dorfmueller HC
R Soc Open Sci; 2021 Mar; 8(3):201991. PubMed ID: 33959354
[No Abstract] [Full Text] [Related]
11. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice.
Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF
Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054
[TBL] [Abstract][Full Text] [Related]
12. The Shock of Strep: Rapid Deaths Due to Group a Streptococcus.
Thompson KM; Sterkel AK; McBride JA; Corliss RF
Acad Forensic Pathol; 2018 Mar; 8(1):136-149. PubMed ID: 31240031
[No Abstract] [Full Text] [Related]
13. Remarkable Genome Stability among emm1 Group A Streptococcus in Belgium over 19 Years.
Coppens J; Xavier BB; Loens K; Lammens C; Ieven M; Matheeussen V; Goossens H; Malhotra-Kumar S
Genome Biol Evol; 2019 May; 11(5):1432-1439. PubMed ID: 31065672
[TBL] [Abstract][Full Text] [Related]
14. Targeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Technique.
Euler CW; Juncosa B; Ryan PA; Deutsch DR; McShan WM; Fischetti VA
PLoS One; 2016; 11(1):e0146408. PubMed ID: 26756207
[TBL] [Abstract][Full Text] [Related]
15. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review.
Ramachandran G
Virulence; 2014 Jan; 5(1):213-8. PubMed ID: 24193365
[TBL] [Abstract][Full Text] [Related]
16. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
Reglinski M; Sriskandan S
Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
[TBL] [Abstract][Full Text] [Related]
17. Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance.
Friães A; Pinto FR; Silva-Costa C; Ramirez M; Melo-Cristino J;
BMC Microbiol; 2012 Nov; 12():280. PubMed ID: 23181337
[TBL] [Abstract][Full Text] [Related]
18. Detection of Streptococcus pyogenes virulence factors by multiplex PCR.
Borek AL; Obszańska K; Hryniewicz W; Sitkiewicz I
Virulence; 2012 Oct; 3(6):529-33. PubMed ID: 23076284
[TBL] [Abstract][Full Text] [Related]
19. Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation.
Turner CE; Sommerlad M; McGregor K; Davies FJ; Pichon B; Chong DL; Farzaneh L; Holden MT; Spratt BG; Efstratiou A; Sriskandan S
PLoS One; 2012; 7(10):e46376. PubMed ID: 23049698
[TBL] [Abstract][Full Text] [Related]
20. Invasive group a streptococcal disease: epidemiology, pathogenesis and management.
Steer AC; Lamagni T; Curtis N; Carapetis JR
Drugs; 2012 Jun; 72(9):1213-27. PubMed ID: 22686614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
